Penn State
Investigational Cancer Drug Deemed Highly Mutagenic in Cell Line Sequencing Study
Using whole-genome sequencing on drug-exposed cell lines, researchers saw high mutation rates in control cell lines intermittently treated with a compound called CX-5461.
In Brief This Week: Ginkgo Bioworks, Cordance Medical, Nucleix, Yale, ERS Genomics, Caris, More
News items for the week of Oct. 23, 2023
Drugs to Treat Smoking Addiction Suggested by Multi-Ancestry Transcriptome-Wide Association Study
The new approach, called TESLA, enables eQTL datasets to be integrated with multi-ancestry GWAS, which the researchers applied to study smoking behaviors.
Tobacco, Alcohol Use Contributors Uncovered With Multi-Ancestry GWAS
Researchers unearthed more than 3,800 tobacco or alcohol use-related variants using data for 3.4 million participants from four ancestry groups.
Penn State Portable Molecular COVID-19 Test Aims to Fill Gap Between Antigen and Molecular Tests
Premium
The test consists of two components, a microfluidic cartridge and a handheld analyzer, and returns results in 45 minutes or less.